SARAH SPITZ: Open Payments
NPI 1043922107 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$599 in 28 payments from 10 companies in 2025. Trend: 2023 $421 · 2024 $605 · 2025 $599
Food & beverage: $599
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $279 |
| Exact Sciences Corporation | 3 | $61 |
| Lilly USA, LLC | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Amneal Pharmaceuticals LLC | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Amgen Inc. | 1 | $16 |
Products named: Rybelsus, Ozempic, Cologuard Collection Kit, MOUNJARO, JARDIANCE, SHINGRIX, CREXONT, Wegovy.
Industry payments across TX — which companies pay providers there.
